论文部分内容阅读
坏死性巩膜炎是一种当相少见的眼病,有报告占巩膜炎的14%。大量资料证明,异常的免疫功能所致的脉管炎,是本病发生的基础。此病险峻而迅速地发展,以至最后将眼球破坏殆尽。临床上一般采用免疫抑制剂治疗。本文报告同种巩膜移植联合全身性免疫抑制疗法治疗坏死性巩膜炎。作者(1978～1988)收集12例(12眼)坏死性巩膜炎作巩膜移植术,手术时的平均年龄63岁(45～87岁),男女之比接近1∶2。其中3例伴有周边性溃疡性角膜炎,1眼有眶周蜂窝织炎,2眼巩膜坏死区眼球穿孔、葡萄膜突出;6例有手术史(5例白内障摘出,1例巩
Necrotizing scleritis is a rare eye disease that accounts for 14% of scleritis. A large number of data show that abnormal immune function caused by vasculitis, is the basis for the occurrence of this disease. The disease is steep and rapid development, and eventually destroy the eyeballs exhausted. In clinical immunosuppressive therapy. This article reports the same kind of scleral transplantation combined with systemic immunosuppressive therapy for the treatment of necrotizing scleritis. The authors (1978 ~ 1988) collected 12 cases (12 eyes) of necrotizing scleritis for scleral transplantation, the average age of surgery 63 years (45 to 87 years), the ratio of men and women close to 1: 2. There were 3 cases with peripheral ulcerative keratitis, 1 case with periorbital cellulitis, 2 eyes with perforation of scleral necrosis, uveal prominent, 6 cases with operation history (5 cases of cataract extraction, 1 case of